Evamist

Product NDC: 64011-215
11-digit product format: 640110215
Labeler code: 64011
Product ID: 64011-215_9218e484-cb59-4bdc-a910-aeea2170646f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: estradiol
Dosage form: SPRAY, METERED
Route: TRANSDERMAL
Labeler: Ther-Rx Corporation
Application: NDA022014
Marketing category: NDA
Marketing start: 2009-07-08
Marketing end: 0000-00-00
Substance: ESTRADIOL
Active strength: 2 mg/1
Pharmacologic classes: Estradiol Congeners [CS],Estrogen [EPC],Estrogen Receptor Agonists [MoA]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	64011-215		D	Discontinued by firm	2026-08-03
excluded package	package	64011-215	64011-215-41	D	Discontinued by firm	2026-08-03
excluded package	package	64011-215	64011-215-42	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64011-215-42	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64011-215-41	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64011-215-42	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64011-215-41	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64011-215-42	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64011-215-41	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64011-215-42	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64011-215-41	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64011-215-42	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64011-215-41	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64011-215-42	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64011-215-41	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64011-215-42	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64011-215-41	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64011-215-42	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64011-215-41	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64011-215-42	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64011-215-41	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64011-215-42	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64011-215-41	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64011-215-42	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64011-215-41	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64011-215-42	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64011-215-41	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64011-215-41	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64011-215-42	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	64011-215-41	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	64011-215-42	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022014-001	EVAMIST	ESTRADIOL	1.53MG/SPRAY	SPRAY / TRANSDERMAL		RLD, RS	2007-07-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022014-001	EVAMIST	1.53MG/SPRAY	SPRAY / TRANSDERMAL	RLD, RS	2007-07-27	`cb3db0bc1861…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022014-001	6978945	2022-07-31	Drug product	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022014-001	6978945	2022-07-31	Drug product	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022014-001	6978945	2022-07-31	Drug product	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022014-001	6978945	2022-07-31	Drug product	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022014-001	6978945	2022-07-31	Drug product	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022014-001	6978945	2022-07-31	Drug product	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022014-001	6978945	2022-07-31	Drug product	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022014-001	6978945	2022-07-31	Drug product	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022014-001	6978945	2022-07-31	Drug product	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022014-001	6978945	2022-07-31	Drug product	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022014-001	6978945	2022-07-31	Drug product	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022014-001	6978945	2022-07-31	Drug product	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022014-001	6978945	2022-07-31	Drug product	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N022014-001	6978945	2022-07-31	Drug product	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022014-001	6978945	2022-07-31	Drug product	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022014-001	6978945	2022-07-31	Drug product	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022014-001	6978945	2022-07-31	Drug product	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022014-001	6978945	2022-07-31	Drug product	`cb3db0bc1861…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
64011-215-41	2021-08-20	These highlights do not include all the information needed to use EVAMIST safely and effectively. See full prescribing information for EVAMIST. EVAMIST (estradiol transdermal spray) Initial U.S. Approval: 1975
64011-215-42	2021-08-20	These highlights do not include all the information needed to use EVAMIST safely and effectively. See full prescribing information for EVAMIST. EVAMIST (estradiol transdermal spray) Initial U.S. Approval: 1975
64011-215-41	2020-01-31	These highlights do not include all the information needed to use EVAMIST safely and effectively. See full prescribing information for EVAMIST. EVAMIST (estradiol transdermal spray) Initial U.S. Approval: 1975
64011-215-42	2020-01-31	These highlights do not include all the information needed to use EVAMIST safely and effectively. See full prescribing information for EVAMIST. EVAMIST (estradiol transdermal spray) Initial U.S. Approval: 1975

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
64011-215-41	ML - Milliliter	64011-215	a7731324-2e1c-42e5-ae0e-e741e2ea1107	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
estradiol	ACTIVE INGREDIENT	4TI98Z838E	EVAMIST (ESTRADIOL) SPRAY, METERED [THER-RX CORPORATION]	12
estradiol	ACTIVE MOIETY	4TI98Z838E	EVAMIST (ESTRADIOL) SPRAY, METERED [THER-RX CORPORATION]	12
alcohol	INACTIVE INGREDIENT	3K9958V90M	EVAMIST (ESTRADIOL) SPRAY, METERED [THER-RX CORPORATION]	12
octisalate	INACTIVE INGREDIENT	4X49Y0596W	EVAMIST (ESTRADIOL) SPRAY, METERED [THER-RX CORPORATION]	12
ESTRADIOL	ACTIVE INGREDIENT	4TI98Z838E	EVAMIST (ESTRADIOL) SPRAY, METERED [PHYSICIANS TOTAL CARE, INC.]	1
ESTRADIOL	ACTIVE MOIETY	4TI98Z838E	EVAMIST (ESTRADIOL) SPRAY, METERED [PHYSICIANS TOTAL CARE, INC.]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	EVAMIST (ESTRADIOL) SPRAY, METERED [PHYSICIANS TOTAL CARE, INC.]	1
OCTISALATE	INACTIVE INGREDIENT	4X49Y0596W	EVAMIST (ESTRADIOL) SPRAY, METERED [PHYSICIANS TOTAL CARE, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Evamist	ESTRADIOL	Padagis US LLC	9a0aa631-133d-406b-9d32-8a1a99af4e50	2024-10-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 022014 application number: NDA022014

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4TI98Z838E	ESTRADIOL	50-28-2	ESTRADIOL

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Evamist	Ther-Rx Corporation \| KV Pharmaceutical \| DPT Laboratories Ltd.	2014-03-31	HUMAN PRESCRIPTION DRUG LABEL	12